Literature DB >> 2507485

Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients.

M Mariyama1, K Kishi, K Nakamura, H Obata, S Nishimura.   

Abstract

Point mutations at the 12th codon of c-Ki-ras in pancreatic cancer from Japanese patients were examined using the polymerase chain reaction, followed by cloning of the amplified gene fragments in pTZ phagemid and nucleotide sequence determination. The frequency of the point mutations found in the tumors was quite high (75%). The mutation most frequently detected was a G---A transition at the second position of codon 12 (GGT---GAT), but other types of mutations such as GGT----GTT and GGT----CGT were also found. In one case, silent mutation of GGT to GGC was detected in addition to the frequent mutation of GGT to GAT. These observations suggest that the 12th codon of pancreatic c-Ki-ras is highly mutatable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507485      PMCID: PMC5917815          DOI: 10.1111/j.1349-7006.1989.tb01687.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Activation of the c-K-ras oncogene in a human pancreas carcinoma.

Authors:  H Hirai; T Okabe; Y Anraku; M Fujisawa; A Urabe; F Takaku
Journal:  Biochem Biophys Res Commun       Date:  1985-02-28       Impact factor: 3.575

Review 3.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

4.  Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia.

Authors:  J L Bos; D Toksoz; C J Marshall; M Verlaan-de Vries; G H Veeneman; A J van der Eb; J H van Boom; J W Janssen; A C Steenvoorden
Journal:  Nature       Date:  1985 Jun 27-Jul 3       Impact factor: 49.962

5.  Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.

Authors:  H Yamada; H Sakamoto; M Taira; S Nishimura; Y Shimosato; M Terada; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1986-04

6.  Mutations in N-ras predominate in acute myeloid leukemia.

Authors:  J L Bos; M Verlaan-de Vries; A J van der Eb; J W Janssen; R Delwel; B Löwenberg; L P Colly
Journal:  Blood       Date:  1987-04       Impact factor: 22.113

7.  Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.

Authors:  C J Farr; R K Saiki; H A Erlich; F McCormick; C J Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

8.  A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.

Authors:  H Hirai; Y Kobayashi; H Mano; K Hagiwara; Y Maru; M Omine; H Mizoguchi; J Nishida; F Takaku
Journal:  Nature       Date:  1987 Jun 4-10       Impact factor: 49.962

9.  Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization.

Authors:  J L Bos; M Verlaan-de Vries; A M Jansen; G H Veeneman; J H van Boom; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1984-12-11       Impact factor: 16.971

10.  Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction.

Authors:  D K Shibata; N Arnheim; W J Martin
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  43 in total

1.  Detection of k-ras gene point mutation in fine needle aspiration and pancreatic juice by sequence special primer method and its clinical significance.

Authors:  Xun-Liang Liu; Cun-Cai Dai; Yi Miao; Jing-Hui Du; Zhao-Song Zhang; Shu-Zhen Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 2.  K-ras mutation and pancreatic adenocarcinoma.

Authors:  C Caldas; S E Kern
Journal:  Int J Pancreatol       Date:  1995-08

Review 3.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

4.  Genetic progression and divergence in pancreatic carcinoma.

Authors:  M Yamano; H Fujii; T Takagaki; N Kadowaki; H Watanabe; T Shirai
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

5.  Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas.

Authors:  K Wakita; H Ohyanagi; K Yamamoto; T Tokuhisa; Y Saitoh
Journal:  Int J Pancreatol       Date:  1992-02

6.  Pancreatic adenocarcinomas frequently show p53 gene mutations.

Authors:  A Scarpa; P Capelli; K Mukai; G Zamboni; T Oda; C Iacono; S Hirohashi
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Evidence for aldosterone-dependent growth of renal cell carcinoma.

Authors:  Sharon King; Susan Bray; Sarah Galbraith; Lesley Christie; Stewart Fleming
Journal:  Int J Exp Pathol       Date:  2014-05-07       Impact factor: 1.925

8.  Genetics talks to epigenetics? The interplay between sequence variants and chromatin structure.

Authors:  Silvio Zaina; Elva L Pérez-Luque; Gertrud Lund
Journal:  Curr Genomics       Date:  2010-08       Impact factor: 2.236

9.  Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation.

Authors:  Lisa D Mills; Yaqing Zhang; Ronald J Marler; Marta Herreros-Villanueva; Lizhi Zhang; Luciana L Almada; Fergus Couch; Cynthia Wetmore; Marina Pasca di Magliano; Martin E Fernandez-Zapico
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

10.  Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.

Authors:  J A DiGiuseppe; R H Hruban; G J Offerhaus; M J Clement; F M van den Berg; J L Cameron; A D van Mansfeld
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.